Positive ENA Screen: What Do Ro, La, Sm, RNP, Scl-70 and Jo-1 Mean?

A positive ENA screen means the laboratory found antibodies against extractable nuclear antigens, which are proteins inside the cell nucleus. These antibodies are linked with autoimmune conditions such as lupus, Sjögren's disease, mixed connective tissue disease, systemic sclerosis and myositis, but a positive screen does not diagnose any of them on its own.

Your report may show an overall ENA screen result, a list of named antibodies, or both, and panel contents differ between laboratories. ENA testing is usually requested after a positive ANA in someone with symptoms of an autoimmune condition; for the ANA result itself, see the separate guide on a positive ANA without a diagnosis.

A blood result is not a reason to delay care for new or serious symptoms. Call local emergency services or go to an emergency department for trouble breathing, shortness of breath together with difficulty swallowing, chest pain that could be a heart problem, or severe pain.

Contact your clinician before a routine review if you notice any of the following. Write down when each symptom started so it can be reviewed alongside the antibody result.

• New or worsening muscle weakness, especially in the shoulders or hips.
• Difficulty swallowing, a new cough or breathlessness.
• Fever without a clear cause, new rashes or joint swelling.
• Persistent dry eyes and dry mouth.

Each antibody has typical associations, but none of them diagnoses a condition alone. Lab Tests Online UK and Cleveland Clinic describe these patterns:

• Ro (SSA): found in about three-quarters of people with Sjögren's disease, and also in lupus and some other conditions.
• La (SSB): linked with Sjögren's disease and lupus, and rarely found without Ro.
• Sm (Smith): a very specific marker for lupus, though only around 30% of people with lupus have it.
• RNP (U1-RNP): found in nearly all people with mixed connective tissue disease, and also in lupus and systemic sclerosis.
• Scl-70 (topoisomerase I): highly specific for systemic sclerosis (scleroderma).
• Jo-1: found in a subset of people with polymyositis or dermatomyositis, especially those with interstitial lung disease.

MedlinePlus notes that some healthy people have autoantibodies, and that a positive result does not necessarily mean an autoimmune disease. Cleveland Clinic explains that people without autoimmune disease more often have a positive ANA alone and a negative ENA panel, so a positive named antibody usually deserves a careful review of symptoms and examination.

How the result is interpreted depends on which antibody is present, whether the result was weak or strong, and whether you have symptoms that fit a related condition. A clinician, often a rheumatologist, weighs these together.

Cleveland Clinic explains that a clinician looks at the ENA results together with your symptoms and other test results before making any diagnosis. What follows depends on which antibody is present. For example, Ro or La may lead to questions about dry eyes and dry mouth, Jo-1 to questions about muscle strength and breathing, and Scl-70 to questions about features of systemic sclerosis.

NIAMS describes the main symptoms of Sjögren's disease as dry eyes, which may burn, itch or feel gritty, and a dry mouth that can make swallowing, speaking and tasting harder. Fatigue, joint pain and muscle aches can also occur. Note any of these, even if they seem minor, because they help the clinician decide whether a related condition is present.

Further assessment may include examination, other blood or urine tests, or referral to a rheumatologist. Not every positive result leads to a diagnosis; sometimes the plan is to watch for new symptoms.

Ro (SSA) and La (SSB) antibodies can cross the placenta during pregnancy. In some babies they cause neonatal lupus, which can include a temporary rash and, less commonly, congenital heart block. Cleveland Clinic states that heart block affects fewer than 2% of babies born to mothers with these antibodies, and that the risk is higher after a previously affected pregnancy.

A person can carry these antibodies without any symptoms, and some people only learn they have them after a baby is diagnosed. For people known to have them, Cleveland Clinic describes fetal heart scans (echocardiograms) starting around the middle of pregnancy to look for heart block. If you have Ro or La antibodies and are pregnant or planning pregnancy, tell your pregnancy team and rheumatology team so they can plan any monitoring.

The neonatal lupus rash is usually temporary and clears within the first year as the mother's antibodies leave the baby's body. Heart block is uncommon, even when these antibodies are present.

Not usually after a positive result. A UK NHS immunology service notes that repeating positive ENA antibodies is nearly never useful. Testing may be repeated if an earlier panel was negative but symptoms continue, or if new symptoms suggest a different condition. Ask what a repeat test would change before arranging one.

Bring the full report showing each named antibody, the result band or level, the sample date and any earlier ANA, anti-dsDNA or rheumatoid factor results.

• Which specific antibody was positive, and how strong was the result?
• Which conditions is this antibody linked with, and do my symptoms fit any of them?
• Do I need further tests, such as lung, muscle or kidney assessment, or a rheumatology referral?
• If I have Ro or La antibodies, what should happen if I plan a pregnancy?
• Which new symptoms should make me contact you sooner?

On SameCase, patients and verified doctors share de-identified cases. Seeing how others with the same named antibody described their symptoms and follow-up can help you organise your own history and prepare questions for your appointment. Similar cases cannot diagnose you or predict your course; your clinician interprets your results.